Hi, Subscriber

Bilal Coulibaly: Everything you need to know

Bilal Coulibaly

Bilal Coulibaly

SF
Washington Wizards

Status

OUT - Heel - Inflammation Expected Return: 2026-10-01

STATS

Bilal Coulibaly

Bilal Coulibaly Career Stats  

  • Career Averages

    PTS
    REB
    AST
    BLK
    STL
    10.8
    4.5
    2.6
    0.8
    1.2
    Year GP GS MIN PTS REB AST BLK STL TO DD2 TD3 3PM 3PA 3P% 2PM 2PA 2P% FGM FGA FG% FTM FTA FT% OREB DREB PF A/TO +/- TS%
    2025-26 56 56 26.2 11.7 4.3 2.6 1.0 1.3 1.4 0 0 1.2 3.6 31.9% 2.9 6.0 49.0% 4.1 9.7 42.5% 2.4 3.2 74.6% 0.9 3.5 2.3 1.8 -414 53.1%
    2024-25 59 59 33.0 12.3 5.0 3.4 0.7 1.3 2.1 3 1 1.1 3.8 28.1% 3.4 6.8 50.0% 4.5 10.6 42.1% 2.3 3.1 74.6% 1.5 3.4 2.4 1.6 -587 51.5%
    2023-24 63 15 27.2 8.4 4.1 1.7 0.8 0.9 1.4 1 0 1.0 2.9 34.6% 2.0 3.9 50.2% 3.0 6.9 43.5% 1.5 2.1 70.2% 0.9 3.2 2.2 1.3 -419 54.3%
    Career
    178
    130
    28.8
    10.8
    4.5
    2.6
    0.8
    1.2
    1.6
    4
    1
    1.1
    3.4
    31.3%
    2.7
    5.5
    49.7%
    3.8
    9.0
    42.6%
    2.0
    2.8
    73.4%
    1.1
    3.4
    2.3
    1.5
    -1420
    52.8%
Bilal Coulibaly

Bilal Coulibaly Game Log   2025-26

  • Regular Season
     
    Date
    Opp
    Result
    MIN
    PTS
    REB
    AST
    BLK
    STL
    TO
    3PA
    3PM
    3P%
    2PA
    2PM
    2P%
    FGA
    FGM
    FG%
    FTA
    FTM
    FT%
    OREB
    DREB
    A/TO
    +/-
    PF
    PER
    TS%
    4/10
    MIA
    L 140-117
    22
    25
    5
    5
    1
    1
    1
    3
    2
    66.7%
    13
    7
    53.8%
    16
    9
    56.3%
    5
    5
    100.0%
    3
    2
    5.0
    +3
    0
    32
    68.7%
    4/7
    CHI
    L 129-98
    23
    19
    3
    1
    2
    0
    1
    3
    2
    66.7%
    7
    5
    71.4%
    10
    7
    70.0%
    6
    3
    50.0%
    1
    2
    1.0
    -22
    1
    21
    75.2%
    4/4
    MIA
    L 152-136
    25
    12
    3
    2
    3
    2
    0
    2
    0
    0.0%
    11
    5
    45.5%
    13
    5
    38.5%
    4
    2
    50.0%
    1
    2
    0.0
    -20
    1
    14
    40.7%
    4/1
    PHI
    L 153-131
    19
    12
    2
    0
    0
    1
    2
    2
    0
    0.0%
    8
    5
    62.5%
    10
    5
    50.0%
    2
    2
    100.0%
    0
    2
    0.0
    -32
    0
    9
    55.1%
    3/29
    POR
    L 123-88
    24
    4
    5
    2
    0
    0
    2
    5
    0
    0.0%
    9
    2
    22.2%
    14
    2
    14.3%
    0
    0
    0.0%
    1
    4
    1.0
    -32
    2
    5
    14.3%
    3/27
    GSW
    L 131-126
    19
    21
    6
    2
    1
    0
    0
    9
    4
    44.4%
    7
    4
    57.1%
    16
    8
    50.0%
    2
    1
    50.0%
    1
    5
    0.0
    -7
    0
    21
    62.2%
    3/25
    UTA
    W 133-110
    18
    11
    2
    3
    0
    3
    2
    1
    0
    0.0%
    8
    4
    50.0%
    9
    4
    44.4%
    4
    3
    75.0%
    0
    2
    1.5
    +16
    1
    10
    51.1%
    3/22
    NYK
    L 145-113
    29
    13
    5
    2
    2
    3
    3
    3
    1
    33.3%
    9
    4
    44.4%
    12
    5
    41.7%
    3
    2
    66.7%
    1
    4
    0.7
    -21
    1
    15
    48.8%
    3/21
    OKC
    L 132-111
    33
    21
    4
    4
    2
    1
    1
    5
    3
    60.0%
    10
    5
    50.0%
    15
    8
    53.3%
    2
    2
    100.0%
    0
    4
    4.0
    +4
    3
    22
    66.1%
    3/16
    GSW
    L 125-117
    32
    21
    8
    4
    0
    1
    2
    2
    2
    100.0%
    8
    5
    62.5%
    10
    7
    70.0%
    6
    5
    83.3%
    1
    7
    2.0
    +6
    4
    27
    83.1%
    3/14
    BOS
    L 111-100
    24
    12
    4
    1
    2
    1
    1
    5
    2
    40.0%
    5
    2
    40.0%
    10
    4
    40.0%
    2
    2
    100.0%
    1
    3
    1.0
    -15
    1
    14
    55.1%
    3/12
    ORL
    L 136-131
    36
    29
    5
    5
    1
    1
    3
    11
    5
    45.5%
    10
    4
    40.0%
    21
    9
    42.9%
    6
    6
    100.0%
    2
    3
    1.7
    -11
    5
    22
    61.3%
    3/10
    MIA
    L 150-129
    34
    10
    6
    7
    0
    1
    1
    1
    0
    0.0%
    6
    2
    33.3%
    7
    2
    28.6%
    8
    6
    75.0%
    0
    6
    7.0
    -19
    3
    17
    47.5%
    3/8
    NOP
    L 138-118
    23
    5
    4
    1
    0
    0
    0
    7
    1
    14.3%
    5
    0
    0.0%
    12
    1
    8.3%
    2
    2
    100.0%
    1
    3
    0.0
    -13
    4
    3
    19.4%
    3/5
    UTA
    L 122-112
    34
    17
    3
    2
    0
    3
    3
    4
    2
    50.0%
    6
    5
    83.3%
    10
    7
    70.0%
    4
    1
    25.0%
    0
    3
    0.7
    -5
    3
    15
    72.3%
    3/3
    ORL
    L 126-109
    24
    6
    6
    3
    0
    0
    1
    6
    0
    0.0%
    6
    3
    50.0%
    12
    3
    25.0%
    0
    0
    0.0%
    0
    6
    3.0
    -25
    3
    2
    25.0%
    3/2
    HOU
    L 123-118
    26
    23
    1
    0
    2
    1
    1
    7
    5
    71.4%
    9
    4
    44.4%
    16
    9
    56.3%
    0
    0
    0.0%
    0
    1
    0.0
    +4
    2
    18
    71.9%
    2/28
    TOR
    L 134-125
    22
    14
    5
    4
    0
    1
    2
    3
    2
    66.7%
    7
    4
    57.1%
    10
    6
    60.0%
    2
    0
    0.0%
    2
    3
    2.0
    -4
    1
    18
    64.3%
    2/26
    ATL
    L 126-96
    22
    10
    5
    1
    0
    1
    0
    2
    0
    0.0%
    8
    4
    50.0%
    10
    4
    40.0%
    2
    2
    100.0%
    1
    4
    0.0
    -1
    3
    9
    46.0%
    2/24
    ATL
    L 119-98
    23
    8
    6
    4
    4
    2
    1
    2
    0
    0.0%
    7
    3
    42.9%
    9
    3
    33.3%
    3
    2
    66.7%
    0
    6
    4.0
    -20
    1
    18
    38.8%
    2/22
    CHA
    L 129-112
    17
    17
    2
    2
    2
    1
    0
    4
    3
    75.0%
    5
    3
    60.0%
    9
    6
    66.7%
    4
    2
    50.0%
    1
    1
    0.0
    -6
    0
    20
    79.0%
    2/20
    IND
    W 131-118
    21
    13
    3
    3
    2
    1
    3
    3
    1
    33.3%
    9
    5
    55.6%
    12
    6
    50.0%
    0
    0
    0.0%
    1
    2
    1.0
    +16
    1
    12
    54.2%
    2/19
    IND
    W 112-105
    23
    12
    4
    5
    0
    3
    1
    3
    1
    33.3%
    6
    3
    50.0%
    9
    4
    44.4%
    4
    3
    75.0%
    1
    3
    5.0
    +5
    1
    18
    55.8%
    2/11
    CLE
    L 138-113
    24
    13
    0
    2
    1
    2
    0
    4
    1
    25.0%
    5
    4
    80.0%
    9
    5
    55.6%
    3
    2
    66.7%
    0
    0
    0.0
    -18
    2
    13
    63.0%
    2/8
    MIA
    L 132-101
    33
    7
    4
    1
    1
    1
    4
    4
    1
    25.0%
    3
    1
    33.3%
    7
    2
    28.6%
    2
    2
    100.0%
    0
    4
    0.3
    -4
    4
    4
    44.4%
    2/5
    DET
    W 126-117
    36
    11
    5
    4
    1
    1
    3
    4
    1
    25.0%
    8
    3
    37.5%
    12
    4
    33.3%
    3
    2
    66.7%
    1
    4
    1.3
    -1
    4
    10
    41.3%
    2/3
    NYK
    L 132-101
    24
    3
    2
    2
    0
    1
    1
    3
    1
    33.3%
    1
    0
    0.0%
    4
    1
    25.0%
    2
    0
    0.0%
    0
    2
    2.0
    -30
    1
    1
    30.7%
    2/1
    SAC
    W 116-112
    21
    15
    1
    3
    0
    2
    1
    1
    0
    0.0%
    8
    5
    62.5%
    9
    5
    55.6%
    5
    5
    100.0%
    0
    1
    3.0
    -2
    3
    16
    67.0%
    1/30
    LAL
    L 142-111
    24
    7
    2
    2
    0
    0
    0
    5
    0
    0.0%
    6
    3
    50.0%
    11
    3
    27.3%
    2
    1
    50.0%
    1
    1
    0.0
    -22
    0
    2
    29.5%
    1/29
    MIL
    W 109-99
    27
    8
    10
    1
    2
    2
    1
    1
    0
    0.0%
    5
    3
    60.0%
    6
    3
    50.0%
    2
    2
    100.0%
    3
    7
    1.0
    +14
    3
    19
    58.1%
    1/27
    POR
    W 115-111
    27
    5
    5
    6
    2
    2
    0
    1
    1
    100.0%
    1
    0
    0.0%
    2
    1
    50.0%
    2
    2
    100.0%
    1
    4
    0.0
    +19
    0
    20
    86.8%
    1/14
    LAC
    L 119-105
    9
    3
    2
    0
    0
    0
    0
    0
    0
    0.0%
    1
    1
    100.0%
    1
    1
    100.0%
    1
    1
    100.0%
    0
    2
    0.0
    -11
    0
    6
    104.2%
    1/11
    PHX
    L 112-93
    28
    12
    4
    1
    1
    2
    0
    5
    2
    40.0%
    5
    2
    40.0%
    10
    4
    40.0%
    2
    2
    100.0%
    1
    3
    0.0
    -13
    4
    12
    55.1%
    1/9
    NOP
    L 128-107
    29
    8
    5
    4
    1
    1
    2
    2
    1
    50.0%
    4
    1
    25.0%
    6
    2
    33.3%
    6
    3
    50.0%
    0
    5
    2.0
    -26
    5
    7
    46.3%
    1/7
    PHI
    L 131-110
    28
    18
    1
    2
    0
    0
    1
    5
    2
    40.0%
    9
    5
    55.6%
    14
    7
    50.0%
    2
    2
    100.0%
    0
    1
    2.0
    -22
    5
    9
    60.5%
    1/6
    ORL
    W 120-112
    34
    14
    8
    3
    0
    5
    2
    3
    1
    33.3%
    5
    3
    60.0%
    8
    4
    50.0%
    6
    5
    83.3%
    3
    5
    1.5
    +23
    3
    23
    65.8%
    1/4
    MIN
    L 141-115
    27
    6
    4
    1
    2
    0
    0
    2
    0
    0.0%
    4
    3
    75.0%
    6
    3
    50.0%
    0
    0
    0.0%
    1
    3
    0.0
    -24
    3
    7
    50.0%
    1/2
    BKN
    W 119-99
    29
    11
    8
    4
    2
    4
    2
    1
    0
    0.0%
    7
    2
    28.6%
    8
    2
    25.0%
    8
    7
    87.5%
    3
    5
    2.0
    +10
    2
    23
    47.7%
    12/31
    MIL
    W 114-113
    25
    10
    5
    2
    0
    2
    1
    4
    1
    25.0%
    4
    1
    25.0%
    8
    2
    25.0%
    8
    5
    62.5%
    1
    4
    2.0
    +4
    5
    8
    43.4%
    12/29
    PHX
    L 115-101
    26
    13
    7
    3
    1
    0
    3
    5
    2
    40.0%
    3
    1
    33.3%
    8
    3
    37.5%
    6
    5
    83.3%
    0
    7
    1.0
    -10
    4
    15
    61.1%
    12/28
    MEM
    W 116-112
    28
    14
    8
    2
    2
    3
    1
    3
    0
    0.0%
    12
    6
    50.0%
    15
    6
    40.0%
    2
    2
    100.0%
    3
    5
    2.0
    +3
    4
    16
    44.1%
    12/26
    TOR
    W 138-117
    25
    21
    8
    1
    1
    3
    2
    4
    1
    25.0%
    10
    7
    70.0%
    14
    8
    57.1%
    5
    4
    80.0%
    2
    6
    0.5
    +5
    3
    25
    64.8%
    12/23
    CHA
    L 126-109
    23
    14
    5
    1
    1
    0
    1
    9
    3
    33.3%
    4
    2
    50.0%
    13
    5
    38.5%
    2
    1
    50.0%
    2
    3
    1.0
    -11
    0
    12
    50.4%
    12/18
    SAS
    L 119-94
    22
    3
    4
    2
    0
    1
    3
    4
    0
    0.0%
    3
    1
    33.3%
    7
    1
    14.3%
    2
    1
    50.0%
    1
    3
    0.7
    -18
    2
    2
    19.0%
    12/2
    PHI
    L 121-102
    24
    2
    5
    2
    1
    1
    1
    3
    0
    0.0%
    2
    1
    50.0%
    5
    1
    20.0%
    0
    0
    0.0%
    1
    4
    2.0
    -20
    0
    7
    20.0%
    12/1
    MIL
    W 129-126
    32
    7
    5
    2
    1
    3
    3
    4
    1
    25.0%
    5
    2
    40.0%
    9
    3
    33.3%
    1
    0
    0.0%
    0
    5
    0.7
    -1
    3
    6
    37.1%
    11/28
    IND
    L 119-86
    30
    11
    4
    2
    1
    1
    4
    5
    2
    40.0%
    4
    2
    50.0%
    9
    4
    44.4%
    2
    1
    50.0%
    0
    4
    0.5
    -17
    4
    7
    55.7%
    11/25
    ATL
    W 132-113
    34
    9
    3
    4
    1
    2
    1
    3
    0
    0.0%
    3
    2
    66.7%
    6
    2
    33.3%
    6
    5
    83.3%
    0
    3
    4.0
    +29
    5
    10
    52.1%
    11/22
    CHI
    L 121-120
    25
    7
    2
    3
    0
    0
    1
    1
    1
    100.0%
    5
    1
    20.0%
    6
    2
    33.3%
    2
    2
    100.0%
    1
    1
    3.0
    +1
    4
    2
    50.9%
    11/21
    TOR
    L 140-110
    26
    9
    3
    2
    0
    2
    1
    5
    0
    0.0%
    1
    1
    100.0%
    6
    1
    16.7%
    8
    7
    87.5%
    0
    3
    2.0
    -19
    2
    11
    47.3%
    11/19
    MIN
    L 120-109
    29
    13
    4
    4
    2
    0
    1
    3
    2
    66.7%
    3
    3
    100.0%
    6
    5
    83.3%
    1
    1
    100.0%
    0
    4
    4.0
    -2
    3
    20
    100.9%
    11/16
    BKN
    L 129-106
    27
    6
    3
    4
    2
    2
    0
    0
    0
    0.0%
    6
    2
    33.3%
    6
    2
    33.3%
    2
    2
    100.0%
    0
    3
    0.0
    -1
    1
    12
    43.6%
    11/5
    BOS
    L 136-107
    16
    1
    2
    3
    0
    0
    2
    3
    0
    0.0%
    2
    0
    0.0%
    5
    0
    0.0%
    2
    1
    50.0%
    1
    1
    1.5
    -8
    2
    3
    8.5%
    11/3
    NYK
    L 119-102
    27
    15
    7
    2
    0
    2
    4
    5
    3
    60.0%
    6
    2
    33.3%
    11
    5
    45.5%
    3
    2
    66.7%
    1
    6
    0.5
    -13
    5
    13
    60.9%
    11/1
    ORL
    L 125-94
    26
    10
    2
    4
    1
    1
    0
    2
    0
    0.0%
    8
    3
    37.5%
    10
    3
    30.0%
    6
    4
    66.7%
    1
    1
    0.0
    -18
    3
    8
    39.6%
    10/30
    OKC
    L 127-108
    24
    16
    8
    4
    3
    1
    4
    7
    2
    28.6%
    5
    4
    80.0%
    12
    6
    50.0%
    2
    2
    100.0%
    1
    7
    1.0
    -12
    0
    23
    62.1%
    Regular Season Totals
    26.2
    11.7
    4.3
    2.6
    1.0
    1.3
    1.4
    3.6
    1.2
    31.9%
    6.0
    2.9
    49.0%
    9.7
    4.1
    42.5%
    3.2
    2.4
    74.6%
    0.9
    3.5
    1.8
    -414
    2.3
    15.5
    53.1%
Bilal Coulibaly

Bilal Coulibaly Player Profile  

Team Washington Wizards
Birthdate 7/26/2004 (21)
Status ACT
HT/WT 6'7", 195 lbs
Draft Info 2023: Rd 1; Pk 7 (IND)
Birthplace Saint-Cloud,, FRA
Position SF
Experience 2 seasons
2025 Salary $7,518,783

Career History

Washington Wizards 2023-Present (3 seasons)

Bilal Coulibaly: Breaking News

Out for Sunday

Coulibaly (heel) won't play Sunday against the Cavaliers. Coulibaly will skip Washington's regular-season finale, which should result in Will Riley returning to the first unit, and there will be more minutes available for Justin Champagnie. Coulibaly will end his 2025-26 season with averages of 11.7 points, 4.3 rebounds, 2.6 assists, 1.2 triples, 1.3 steals and 1.0 blocks per game.

Scores 25 points in another loss

Coulibaly ended Friday's 140-117 loss to the Heat with 25 points (9-16 FG, 2-3 3Pt, 5-5 FT), five rebounds, five assists, one block and one steal over 22 minutes. Coulibaly is expected to be one of the top players in the future of the franchise, and the young Frenchman has shown promise at times throughout the season. This was the first time he reached the 20-point mark since March 27, and he's scored 20-plus points seven times this season. It's hard to see him stand out individually due to all the struggles the Wizards have had in recent weeks, but the talent and upside are clearly there. Coulibaly is worth keeping on your rosters in dynasty formats without a doubt.

Cleared to play

Coulibaly (heel) is available for Friday's game against the Heat. The second-year forward is set to return for the second leg of this back-to-back set. Coulibaly may see a modest workload, with the Wizards erring on the side of caution with their key players.

Bilal Coulibaly: More News

NBA Mock Draft 2026: Big Moves by Teams, Players

NBA Mock Draft 2026: Big Moves by Teams, Players

Anthony Davis’ NBA Future in Serious Trouble After Alarming Update

Anthony Davis’ NBA Future in Serious Trouble After Alarming Update

Washington Wizards Make Major Decision Regarding Brian Keefe’s Future with Franchise

Washington Wizards Make Major Decision Regarding Brian Keefe’s Future with Franchise

Wizards’ Anthony Davis Addresses D.C. Media for First Time Since Trade

Wizards’ Anthony Davis Addresses D.C. Media for First Time Since Trade

Anthony Davis Drops Brutal Reality Check on the Wizards’ Championship Hopes

Anthony Davis Drops Brutal Reality Check on the Wizards’ Championship Hopes

Wizards Release Brutal Injury Report With Eight Players Out

Wizards Release Brutal Injury Report With Eight Players Out

NBA Mock Draft 2026: NCAA Tournament Risers Head to Final 4

NBA Mock Draft 2026: NCAA Tournament Risers Head to Final 4

Wizards Issue Apology After $10K April Fools Prank on Fan Goes Wrong

Wizards Issue Apology After $10K April Fools Prank on Fan Goes Wrong

NBA Star Anthony Davis Gets New Update Before Sixers Game

NBA Star Anthony Davis Gets New Update Before Sixers Game

Michael Jordan Details How NASCAR Lawsuit Led to Massive Pay Reform

Michael Jordan Details How NASCAR Lawsuit Led to Massive Pay Reform

NBA Mock Draft 2026: So, Who is Your Team Going to Pick?

NBA Mock Draft 2026: So, Who is Your Team Going to Pick?

Wizards Lose 15th Straight as NBA Issues Decision After Thunder Fight

Wizards Lose 15th Straight as NBA Issues Decision After Thunder Fight

Wizards Make Anthony Davis Announcement Ahead of Thunder Game

Wizards Make Anthony Davis Announcement Ahead of Thunder Game

John Wall Opens Up on NBA Exit, New Amazon Prime Role After Viral Moment

John Wall Opens Up on NBA Exit, New Amazon Prime Role After Viral Moment

Trae Young’s Injury Addressed After Wizards-Pistons Game

Trae Young’s Injury Addressed After Wizards-Pistons Game

Wizards Announce Concerning Trae Young News vs Pistons

Wizards Announce Concerning Trae Young News vs Pistons

Wizards Announce Trae Young Injury Update vs. Warriors

Wizards Announce Trae Young Injury Update vs. Warriors

Washington Wizards Announce Trae Young Status Before Warriors Game

Washington Wizards Announce Trae Young Status Before Warriors Game

Washington Wizards Announce Trae Young Status For Celtics Game

Washington Wizards Announce Trae Young Status For Celtics Game

Duke’s Cameron Boozer Looks Up to Wizards Star as NBA Lottery Looms

Duke’s Cameron Boozer Looks Up to Wizards Star as NBA Lottery Looms

Washington Wizards Announce Trae Young Status For Magic Game

Washington Wizards Announce Trae Young Status For Magic Game

Wizards Announce Trae Young’s Status vs Miami Heat

Wizards Announce Trae Young’s Status vs Miami Heat

Angel Reese Drops NSFW Reaction to Brother’s Historic Game

Angel Reese Drops NSFW Reaction to Brother’s Historic Game

NBA Fans Buzzing Over Trae Young’s Viral Moment In Wizards Debut

NBA Fans Buzzing Over Trae Young’s Viral Moment In Wizards Debut

NBA Fans React To Washington Wizards Anthony Davis Announcement

NBA Fans React To Washington Wizards Anthony Davis Announcement

Wizards Get Critical Injury News Before Trae Young Debut

Wizards Get Critical Injury News Before Trae Young Debut

Washington Wizards Make Trae Young Announcement Before Jazz Game

Washington Wizards Make Trae Young Announcement Before Jazz Game

Ex-NBA Guard Sends Clear Shot At Wizards’ Trae Young

Ex-NBA Guard Sends Clear Shot At Wizards’ Trae Young

Angel Reese Has Emotional Statement on Washington Wizards

Angel Reese Has Emotional Statement on Washington Wizards

Trae Young Ejection: Wizards Guard Faces NBA Suspension For Antics Against Rockets

Trae Young Ejection: Wizards Guard Faces NBA Suspension For Antics Against Rockets

Bilal Coulibaly: More News